Ramky Infra subsidiary signs ₹3,000 Cr pharma park pact with MIDC
Ramky Infrastructure Limited's subsidiary, Maha Integrated Life Sciences City Limited, signed a Concession Agreement with MIDC for a ₹3,000 crore High-Tech Pharmaceutical Park. The project, on a PPP basis (DBFOT model), has a 95-year concession period and will boost RIL's order book to ₹13,500 crore.
The project's substantial value (₹3,000 crore) and its contribution to the company's order book (₹13,500 crore) indicate a significant impact on Ramky Infrastructure Limited's business.
The announcement details a significant new order win for a large-scale infrastructure project, which is positive for the company's future revenue and growth prospects.
Ramky Infrastructure Limited (RIL) has announced the execution of a Concession Agreement between the Maharashtra Industrial Development Corporation (MIDC) and Maha Integrated Life Sciences City Limited (MILeS City), a wholly-owned subsidiary of RIL. This agreement is for the development of a High-Tech Pharmaceutical Park at the Dighi Port Industrial Area in Raigad district, Maharashtra.
The project will be implemented on a Public-Private Partnership (PPP) basis using the Design, Build, Finance, Operate and Transfer (DBFOT) model. The estimated project cost is ₹3,000 crore (approximately), including operating income over a 90-year period. The concession period will be 95 years, with RIL expecting to complete the construction phase within the next five years. This project is anticipated to add to RIL's order book, bringing it to ₹13,500 crore.
The High-Tech Pharmaceutical Park will be developed across approximately 1,000 hectares and will feature industrial zones, commercial areas, common infrastructure, utilities, internal road networks, and open spaces. It aims to create a world-class integrated life sciences manufacturing ecosystem with end-to-end infrastructure and shared facilities for pharmaceutical, biotechnology, and life sciences companies. Key elements include integrated infrastructure, advanced utilities, innovation-led R&D centers, incubation hubs, and environmentally responsible operations.
MILeS City will be responsible for the development, operation, maintenance, and management of the project throughout the concession period. The revenue model will comprise land lease premium and lease rental, development charges, maintenance charges for common infrastructure and services, and operational charges for utilities and shared facilities.
This project is expected to enhance regional industrial infrastructure, attract investments in the pharmaceutical and life sciences sectors, and create significant employment opportunities. It will also stimulate growth in ancillary industries and local businesses.
Following this agreement, Ramky Infrastructure Limited's order book stands at approximately ₹13,500 crore. Mr. Sunil S Nair, CEO of Ramky Infrastructure Limited, stated that the agreement is a significant milestone for industrial development and the wider communities, aiming to support employment generation, strengthen regional infrastructure, encourage innovation, and attract long-term investment into Maharashtra.
What to do with a filing like this
Ramky Infrastructure Limited filed this with the NSE as a statutory disclosure, categorised under new orders. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Ramky Infrastructure Limited. Read the original for the full detail.